Concept paper on the need for revision of the guideline on the development of medicinal products for the treatment of smoking
Quality of medicines: questions and answers - Part 2
Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 10, Status: Authorised
European Medicines Agency’s privacy statement for legal entity and bank account validation
Data protection and privacy at EMA
Champix
SME Regulation and reports
20 years supporting small and medium enterprises (SMEs) at EMA report
Product Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 3
Timetable: Marketing authorisation renewal application - ATMP